These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25369980)

  • 1. Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations.
    Hindmarsh PC; Charmandari E
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):557-61. PubMed ID: 25369980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Charmandari E; Johnston A; Brook CG; Hindmarsh PC
    J Endocrinol; 2001 Apr; 169(1):65-70. PubMed ID: 11250647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital adrenal hyperplasia: management during critical illness.
    Charmandari E; Lichtarowicz-Krynska EJ; Hindmarsh PC; Johnston A; Aynsley-Green A; Brook CG
    Arch Dis Child; 2001 Jul; 85(1):26-8. PubMed ID: 11420193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
    Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
    BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia.
    Sarafoglou K; Zimmerman CL; Gonzalez-Bolanos MT; Willis BA; Brundage R
    J Investig Med; 2015 Jan; 63(1):35-41. PubMed ID: 25386671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study.
    Johannsson G; Bergthorsdottir R; Nilsson AG; Lennernas H; Hedner T; Skrtic S
    Eur J Endocrinol; 2009 Jul; 161(1):119-30. PubMed ID: 19383806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
    Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty.
    Charmandari E; Hindmarsh PC; Johnston A; Brook CG
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2701-8. PubMed ID: 11397874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.
    Nella AA; Mallappa A; Perritt AF; Gounden V; Kumar P; Sinaii N; Daley LA; Ling A; Liu CY; Soldin SJ; Merke DP
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4690-4698. PubMed ID: 27680873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia.
    Melin J; Parra-Guillen ZP; Michelet R; Truong T; Huisinga W; Hartung N; Hindmarsh P; Kloft C
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32052005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion.
    Bryan SM; Honour JW; Hindmarsh PC
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3477-80. PubMed ID: 19567522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
    Lennernäs H; Skrtic S; Johannsson G
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise.
    Weise M; Drinkard B; Mehlinger SL; Holzer SM; Eisenhofer G; Charmandari E; Chrousos GP; Merke DP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3679-84. PubMed ID: 15292287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with flutamide decreases cortisol clearance: implications for therapy in congenital adrenal hyperplasia.
    Charmandari E; Johnston A; Honour JW; Brook CG; Hindmarsh PC
    J Pediatr Endocrinol Metab; 2002 Apr; 15(4):435-9. PubMed ID: 12008691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
    Agha A; Liew A; Finucane F; Baker L; O'Kelly P; Tormey W; Thompson CJ
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapy.
    Peters CJ; Hill N; Dattani MT; Charmandari E; Matthews DR; Hindmarsh PC
    Clin Endocrinol (Oxf); 2013 Mar; 78(3):347-51. PubMed ID: 22803584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.
    Mallappa A; Sinaii N; Kumar P; Whitaker MJ; Daley LA; Digweed D; Eckland DJ; Van Ryzin C; Nieman LK; Arlt W; Ross RJ; Merke DP
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1137-45. PubMed ID: 25494662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasia.
    Ross RJ; Rostami-Hodjegan A
    Horm Res; 2005; 64 Suppl 2():67-70. PubMed ID: 16286775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.